HomeCompareSRHBF vs MRK

SRHBF vs MRK: Dividend Comparison 2026

SRHBF yields 6.96% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SRHBF wins by $110.1K in total portfolio value
10 years
SRHBF
SRHBF
● Live price
6.96%
Share price
$0.72
Annual div
$0.05
5Y div CAGR
30.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$166.9K
Annual income
$56,723.24
Full SRHBF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — SRHBF vs MRK

📍 SRHBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSRHBFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SRHBF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SRHBF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SRHBF
Annual income on $10K today (after 15% tax)
$591.92/yr
After 10yr DRIP, annual income (after tax)
$48,214.75/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, SRHBF beats the other by $39,886.34/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SRHBF + MRK for your $10,000?

SRHBF: 50%MRK: 50%
100% MRK50/50100% SRHBF
Portfolio after 10yr
$111.8K
Annual income
$33,260.69/yr
Blended yield
29.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SRHBF
No analyst data
Altman Z
2.1
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SRHBF buys
0
MRK buys
0
No recent congressional trades found for SRHBF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSRHBFMRK
Forward yield6.96%2.76%
Annual dividend / share$0.05$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR30.7%32.7%
Portfolio after 10y$166.9K$56.8K
Annual income after 10y$56,723.24$9,798.13
Total dividends collected$132.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SRHBF vs MRK ($10,000, DRIP)

YearSRHBF PortfolioSRHBF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,610$910.17$11,206$366.19+$404.00SRHBF
2$13,714$1,290.78$12,650$502.35+$1.1KSRHBF
3$16,536$1,862.34$14,407$694.19+$2.1KSRHBF
4$20,436$2,743.00$16,585$967.82+$3.9KSRHBF
5$26,008$4,140.89$19,342$1,363.89+$6.7KSRHBF
6$34,265$6,437.03$22,913$1,947.19+$11.4KSRHBF
7$47,023$10,359.27$27,662$2,823.89+$19.4KSRHBF
8$67,680$17,365.10$34,159$4,173.35+$33.5KSRHBF
9$102,947$30,529.28$43,337$6,308.80+$59.6KSRHBF
10$166,876$56,723.24$56,776$9,798.13+$110.1KSRHBF

SRHBF vs MRK: Complete Analysis 2026

SRHBFStock

StarHub Ltd, an integrated info communications company, provides communications, entertainment, and digital solutions for individuals and corporations in Singapore. The company operates in four segments: Telecommunications, Cyber Security, High Security Assurance Product, and Regional Information Communication Technology. The company provides television subscription and broadcasting services; broadband access, high speed wholesale broadband, and information security systems integration services; security consultancy services; information security and network security surveillance services; petrol station retail and fuel logistics management solutions; hospital information systems solutions; business application solutions and related services; data center and business continuity services; healthcare information technology products and services; and healthcare information technology software, research and development, and support services. It also engages in computer systems integration, other professional, scientific, and technical activities; development and supply of data security products and components; provision of information security and network security surveillance services; sales of information technology security related products; implementation of information communication technology projects; and system integration, supply and implementation of hardware and software solutions, and provision of maintenance services. Further, the company is involved in the development and provision of software as a service application; provision of architecting ICT solutions and project management services; and investment holding and provision of management services. The company was incorporated in 1998 and is headquartered in Singapore. StarHub Ltd is a subsidiary of Asia Mobile Holdings Pte. Ltd.

Full SRHBF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SRHBF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SRHBF vs SCHDSRHBF vs JEPISRHBF vs OSRHBF vs KOSRHBF vs MAINSRHBF vs JNJSRHBF vs ABBVSRHBF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.